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A simpliﬁed protocol for differentiation of
electrophysiologically mature neuronal networks from
human induced pluripotent stem cells
N Gunhanlar1,4, G Shpak1,4, M van der Kroeg1, LA Gouty-Colomer1,5, ST Munshi1, B Lendemeijer1, M Ghazvini2,3, C Dupont2,
WJG Hoogendijk1, J Gribnau2,3, FMS de Vrij1,6 and SA Kushner1,6
Progress in elucidating the molecular and cellular pathophysiology of neuropsychiatric disorders has been hindered by the limited
availability of living human brain tissue. The emergence of induced pluripotent stem cells (iPSCs) has offered a unique alternative
strategy using patient-derived functional neuronal networks. However, methods for reliably generating iPSC-derived neurons with
mature electrophysiological characteristics have been difﬁcult to develop. Here, we report a simpliﬁed differentiation protocol that
yields electrophysiologically mature iPSC-derived cortical lineage neuronal networks without the need for astrocyte co-culture or
specialized media. This protocol generates a consistent 60:40 ratio of neurons and astrocytes that arise from a common forebrain
neural progenitor. Whole-cell patch-clamp recordings of 114 neurons derived from three independent iPSC lines conﬁrmed their
electrophysiological maturity, including resting membrane potential (−58.2 ± 1.0 mV), capacitance (49.1 ± 2.9 pF), action potential
(AP) threshold (−50.9 ± 0.5 mV) and AP amplitude (66.5 ± 1.3 mV). Nearly 100% of neurons were capable of ﬁring APs, of which 79%
had sustained trains of mature APs with minimal accommodation (peak AP frequency: 11.9 ± 0.5 Hz) and 74% exhibited
spontaneous synaptic activity (amplitude, 16.03 ± 0.82 pA; frequency, 1.09 ± 0.17 Hz). We expect this protocol to be of broad
applicability for implementing iPSC-based neuronal network models of neuropsychiatric disorders.
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INTRODUCTION
A detailed knowledge of the pathophysiology underlying the
majority of human neuropsychiatric disorders remains largely
enigmatic. However, functional genomic studies have begun to
offer novel insights into many forms of neurological and
psychiatric illness.1–5 There is widespread consensus that validated
and robust human cellular models for brain disorders would be of
considerable beneﬁt.6,7
The discovery of induced pluripotent stem cells (iPSCs) has
provided the opportunity to investigate the physiology of living
human neurons derived from individual patients.8 Several
protocols have been reported for generating iPSC-derived
neurons based on a variety of different methods. One of the
most commonly employed approaches is neural induction
through embryoid body (EB) formation.9 Another widely imple-
mented method for neural induction is inhibition of the
transforming growth factor-β/SMAD signaling pathway by Noggin
and SB431542.10,11 More recently, Zhang et al.12 reported a novel
method utilizing forced expression of neurogenin-2 (NGN2) with
puromycin selection to generate highly pure networks of
glutamatergic neurons from human embryonic stem cells and
iPSCs. In addition, protocols have been developed for generating
three-dimensional neural cultures using cerebral organoids
cultured in a spinning bioreactor,13 cortical spheroids in free-
ﬂoating conditions14 or three-dimensional Matrigel culture.15
In establishing optimized and standardized methods for
neural differentiation of iPSCs, one of the most important
questions is the functional maturity of the resulting neuronal
networks. The design of optimized neural differentiation protocols
is critical for the reliable generation of functional neurons that can
form active networks and demonstrate mature electrophysiologi-
cal properties. Bardy et al.16 recently reported a signiﬁcant
advance in achieving functionally mature iPSC-derived neuronal
networks. However, the major limitation with this approach is the
requirement for nonstandard culture medium and extracellular
recording solution during the differentiation process and electro-
physiological recording.
Neuron–astrocyte interactions are critical both during early
neurodevelopment and in the adult brain.17 Astrocytes are
involved in the guidance of neuronal precursors and for increasing
the length of neuronal ﬁber projections during development.18
Moreover, astrocytes dynamically modulate synaptic
transmission.19,20 Consequently, the functional maturation of
human pluripotent stem cell-derived neurons is substantially
improved by the presence of astrocytes.14,21 For the derivation of
iPSC-derived neuronal networks, astrocytes can either be intro-
duced through co-culture22–24 or differentiated from a common
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neural progenitor that gives rise to both neurons and astrocytes as
occurs in vivo.9 The co-culture approach allows more ﬂexibility in
having experimental control over the neuron-to-astrocyte ratio
and the source of the co-cultured astrocytes. The major drawback,
however, is the potential for introducing a source of variability,
especially concerning species differences when using co-cultures
of rodent astrocytes with human iPSC-derived neurons. In
contrast, differentiation protocols based on a common progenitor
giving rise to both neurons and astrocytes proceed more similarly
to in vivo neurodevelopment.9
Using the latter approach, we now report a simpliﬁed
differentiation protocol for deriving functionally mature neuronal
networks from iPSCs without the need for astrocyte co-culture or
specialized media.
MATERIALS AND METHODS
Human iPSC lines
Reprogramming of human primary skin ﬁbroblasts from two adult donors
(line 1: male, age 57 years; line 2: female, age 54 years) was performed as
described previously using a single, multicistronic lentiviral vector
encoding OCT4, SOX2, KLF4 and MYC.25 Donors provided written informed
consent in accordance with the Medical Ethical Committee of the Erasmus
University Medical Center. Quality control of iPSC clones was performed by
karyotyping, real-time quantitative PCR and EB differentiation.26 Line 3
(male, newborn) was reprogrammed from cord blood CD34+ cells using
episomal reprogramming (Axol Biosciences, Cambridge, UK).
Differentiation of human iPSCs to neuronal networks
Generation of NPCs. Human iPSC lines 1 and 2 were dissociated from
mouse embryonic ﬁbroblasts with collagenase (100 U ml− 1, Thermo Fisher
Scientiﬁc, Waltham, MA, USA) for 7 min at 37 °C/5% CO2. EBs were
generated by transferring dissociated iPSCs to non-adherent plates in
human embryonic stem cell medium (Dulbecco’s modiﬁed Eagle’s medium
(DMEM)/F12 (Thermo Fisher Scientiﬁc), 20% knockout serum (Thermo
Fisher Scientiﬁc), 1% minimum essential medium/non-essential amino
acid (Sigma-Aldrich, St Louis, MO, USA), 7 nl ml− 1 β-mercaptoethanol
(Sigma-Aldrich), 1% L-glutamine (Thermo Fisher Scientiﬁc) and 1%
penicillin/streptomycin (Thermo Fisher Scientiﬁc)) on a shaker in an
incubator at 37 °C/5% CO2. EBs were grown for 2 days in human embryonic
stem cell medium, changed into neural induction medium (DMEM/F12, 1%
N2 supplement (Thermo Fisher Scientiﬁc), 2 μg ml− 1 heparin (Sigma-
Aldrich) and 1% penicillin/streptomycin) on day 2 (d2) and cultured for
another 4 days in suspension (d3–d6). For generation of neural precursor
cells (NPCs), EBs were slightly dissociated at d7 by trituration and plated
onto laminin-coated 10 cm dishes (20 μg ml− 1 laminin (Sigma-Aldrich) in
DMEM for 30 min at 37 °C), initially using neural induction medium (d7–
14), and then from d15 in NPC medium (DMEM/F12, 1% N2 supplement,
2% B27-RA supplement (Thermo Fisher Scientiﬁc), 1 μg ml− 1 laminin,
20 ng ml− 1 basic ﬁbroblast growth factor (Merck-Millipore, Darmstadt,
Germany) and 1% penicillin/streptomycin). On d15, cells were considered
pre-NPCs (passage 1) and able to be passaged (1:4) and cryopreserved
when conﬂuent. From passage 5, cells were considered NPCs and used for
neural differentiation.
Line 3 NPCs were derived using the protocol reported by Shi et al.9
with modiﬁcations (Axol Biosciences, line ax0015) to examine the
generalizability of our neural differentiation protocol.
Neural differentiation. NPCs (passages 5–11) were plated on sterile
coverslips in 6- or 12-well plates and coated with poly-L-ornithine
(Sigma-Aldrich) for 1 h at room temperature. Coated coverslips were
washed 3 times with sterile water and dried for 30 min. Subsequently, a
100 μl drop of laminin solution (50 μg ml− 1 in water) was placed in the
middle of each coverslip, incubated for 15–30 min at 37 °C/5% CO2 and
then replaced with a 100 μl drop of DMEM until plating of NPCs.
Immediately before plating, NPCs were washed with Dulbecco’s
phosphate-buffered saline and dissociated with collagenase (100 U ml− 1).
One fully conﬂuent 10 cm dish of NPCs was divided over a 12-well plate.
A 100 μl drop of NPC cell suspension was placed on the laminin-coated
spot for 1 h to allow for attachment of NPCs on coverslips in neural
differentiation medium (Neurobasal medium, 1% N2 supplement, 2%
B27-RA supplement, 1% minimum essential medium/non-essential amino
acid, 20 ng ml− 1 brain-derived neurotrophic factor (ProSpec Bio, Rehovot,
Israel), 20 ng ml− 1 glial cell-derived neurotrophic factor (ProSpec Bio), 1 μM
dibutyryl cyclic adenosine monophosphate (Sigma-Aldrich), 200 μM
ascorbic acid (Sigma-Aldrich), 2 μg ml− 1 laminin and 1% penicillin/
streptomycin). After 1 h, 900 μl of neural differentiation medium was
added to each well. Cells were refreshed with medium 3 times per week.
During weeks 1–4, medium was fully refreshed. After 4 weeks of neural
differentiation, only half of the volume of medium per well was refreshed.
Electrophysiology and confocal imaging were performed between 8 and
10 weeks after plating of NPCs.
Immunocytochemistry and quantiﬁcation
Cell cultures were ﬁxed using 4% formaldehyde in phosphate-buffered
saline. Primary antibodies were incubated overnight at 4 °C in labeling
buffer containing 0.05 M Tris, 0.9% NaCl, 0.25% gelatin and 0.5% Triton-X-100
(pH 7.4). The following primary antibodies were used: SOX2, Nestin, MAP2,
TBR1, GAD67, NeuN and glial ﬁbrillary acidic protein (GFAP) (Merck-Millipore);
FOXG1 (ProSci, Poway, CA, USA); Vimentin (Santa Cruz Biotechnology,
Dallas, TX, USA); AFP (R&D Systems, Minneapolis, MN, USA); TRA-1-81 and
Nanog (Beckton Dickinson, Franklin Lakes, NJ, USA); OCT4, BRN2, SATB2,
CUX1, CUX2 and CTIP2 (Abcam, Cambridge, UK); Synapsin, MAP2 (Synaptic
Systems, Göttingen, Germany); and PSD95 (Thermo Fisher Scientiﬁc). The
following secondary antibodies were used: Alexa-488, Alexa-546, Alexa-555
and Cy3 antibodies (Jackson ImmunoResearch, West Grove, PA, USA).
Samples were imbedded in Mowiol 4-88 (Sigma-Aldrich), after which
confocal imaging was performed with a Zeiss LSM700 confocal microscope
using ZEN software (Zeiss, Oberkochen, Germany).
Electrophysiology
Whole-cell patch-clamp recordings. Culture slides were collected from
12-well culture plates. Whole-cell patch-clamp recordings were performed
at 8–10 weeks following the initiation of NPC differentiation. Recording
micropipettes (tip resistance 3–6 MΩ) were ﬁlled with internal solution
composed of (in mM): 130 K-gluconate, 0.1 EGTA, 1 MgCl2, 2 MgATP, 0.3
NaGTP, 10 HEPES, 5 NaCl, 11 KCl and 5 Na2-phosphocreatine (pH 7.4).
Recordings were made at room temperature using a MultiClamp 700B
ampliﬁer (Molecular Devices, Sunnyvale, CA, USA). Signals were sampled and
ﬁltered at 10 and 3 kHz, respectively. The whole-cell capacitance was
compensated and series resistance was monitored throughout the experi-
ment in order to conﬁrm the integrity of the patch seal and the stability of
the recording. Voltage was corrected for liquid junction potential (−14 mV).
The bath was continuously perfused with oxygenated artiﬁcial cerebrospinal
ﬂuid (ACSF) composed of (in mM): 110 NaCl, 2.5 KCl, 2 CaCl2, 10 glucose
and 1 NaH2PO4, 25 NaHCO3, 0.2 ascorbic acid and 2 MgCl2 (pH 7.4). For
voltage-clamp recordings, cells were clamped at −80 mV. Spontaneous
postsynaptic currents were recorded for 3 min. Fast sodium and potassium
currents were evoked by voltage steps ranging from −80 to +50 mV in
10 mV increments. Capacitance was derived from the Clampex 10.2
(Molecular Devices) membrane-test function. For current-clamp recordings,
voltage responses were evoked from a holding potential of −75 mV using
500 ms steps ranging from −20 to +150 pA in 10 pA intervals delivered at
0.5 Hz. Single action potential (AP) properties were calculated from the ﬁrst
evoked AP in response to a depolarizing step. Repetitively ﬁring neurons
were deﬁned as those capable of ﬁring ⩾ 3 mature APs without signiﬁcant
accommodation in response to a depolarizing current step.
Spontaneous AP activity was measured for 3 min using the minimum
hyperpolarizing holding current in which spiking was evident (0–10 pA),
from an initial holding potential of − 80 mV. AP threshold was calculated as
the point at which the second derivative of the AP waveform exceeded
baseline. AP rise and decay times were calculated between 10% and 90%
of the AP amplitude. Data analysis was performed by Clampﬁt 10.2
(Molecular Devices). Spontaneous postsynaptic currents were analyzed by
MiniAnalysis software (Synaptosoft, Fort Lee, NJ, USA).
Equilibration procedure from cell culture medium to ACSF. Before initiating
whole-cell recordings, cell culture medium was gradually replaced with
oxygenated ACSF in order to minimize the impact of the relative difference
in osmolarity (culture medium, 220 mOsm l− 1; ACSF, 305 mOsm l− 1). Into
the 1 ml volume of culture medium per well, 300 μl of oxygenated ACSF
was added for 5 min, after which 300 μl was removed. This replacement
procedure was repeated 5 times at room temperature. Slides were placed
immediately thereafter into the recording chamber with continuous
perfusion of oxygenated ACSF.
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Biocytin labeling. Juxtasomal labeling of neurons was performed using
biocytin (5% w/v internal solution) at 8 weeks following the initiation of
NPC differentiation. With a GΩ seal on the cell soma, neurons were
subjected to 15–20 min of 100–150 pA square-wave current pulses
delivered at 2 Hz. Cultures were ﬁxed using 4% formaldehyde in
phosphate-buffered saline. Secondary staining with Alexa-488-
streptavidin (Jackson ImmunoResearch) was performed in labeling buffer
overnight at 4 °C, after which slides were mounted in Mowiol 4-88 and
imaged with a Zeiss LSM700 confocal microscope using ZEN software
(Zeiss). Sholl analysis and dendrite length quantiﬁcation were performed
using Fiji (ImageJ, National Institutes of Health, Bethesda, MD, USA)
software.27
Electron microscopy
Fixation was performed for 1 h in 2% glutaraldehyde and 0.1 M sodium
cacodylate (NaCac). After rinsing in 0.1 M NaCac, cells were pelleted in 2%
agar and postﬁxed in 2% glutaraldehyde for 15 min. Subsequently, cells
were osmicated for 1 h with 1% OsO4, dehydrated with EtOH and
propylene oxide, followed by embedding in Durcupan Plastic (Fluka,
Buchs, Switzerland) for 72 h. Ultrathin sections (60 nm) were cut using an
ultramicrotome (Leica, Wetzlar, Germany), mounted on nickel grids and
counterstained with uranyl acetate and lead citrate. Imaging was
performed with a CM100 Transmission Electron Microscope (Philips,
Eindhoven, The Netherlands).
Statistical analysis
Statistical comparisons of continuous variables were performed using
analysis of variance with post hoc Tukey’s test, using SPSS (Version 21, IBM,
Armonk, NY, USA). For categorical parameters, Fisher’s exact test was used.
The threshold for statistical signiﬁcance was set at Po0.01 in order to
correct for the 17 different electrophysiological parameters measured.
RESULTS
Generation of forebrain-patterned NPCs from iPSCs
NPCs are capable of generating a diversity of neural lineages,
including both neurons and astrocytes. To generate iPSC-derived
NPCs (lines 1 and 2), iPSCs were detached from feeder cells using
collagenase and suspended colonies were transferred to non-
adherent plates (Supplementary Figure 1). Suspended colonies
were cultured on a shaker that promoted the formation of
spherical EBs (Figure 1a). EBs were cultured for 6 days (d1–d6), of
which the ﬁrst 2 days (d1–d2) were in human embryonic stem cell
medium (knockout serum based) and then 4 days (d3–d6) in
neural induction medium (advanced DMEM with heparin and N2
supplement). On day 7 of differentiation (d7), EBs were gently
dissociated and plated onto laminin-coated dishes in neural
induction medium for 8 days (d7–d14), resulting in a population of
pre-NPCs (passage 1). At d15, pre-NPCs were dissociated by
collagenase and replated onto laminin-coated dishes in NPC
medium (advanced DMEM with N2, B27 supplement and laminin)
containing basic ﬁbroblast growth factor to promote selection and
proliferation of precursor cells. The medium was changed every
other day. Once conﬂuent, cells were passaged 1:4 and could be
cryopreserved in liquid nitrogen. From passage ﬁve, the cells
exhibited a homogeneous morphology and marker proﬁle of
mature NPCs, expressing SOX2, Nestin, Vimentin and the
forebrain-speciﬁc NPC marker FOXG1 (Figure 1b).
Differentiation of to neuronal network cultures
NPCs were utilized between passages 5 and 11 for neural
differentiation. NPCs were plated onto poly-L-ornithine/laminin-
coated coverslips in neural differentiation medium (neurobasal
medium with N2, B27-RA) supplemented with growth factors
brain-derived neurotrophic factor, glial cell-derived neurotrophic
factor, dibutyryl cyclic adenosine monophosphate and ascorbic
acid. Throughout the entire period of neural differentiation,
medium was replaced 3 times per week. During weeks 1–4, the
medium was fully exchanged. From week 5 onwards, only half of
the medium was replaced per exchange. Electrophysiological
recordings and confocal imaging were performed at 8–10 weeks
following the initiation of NPC differentiation. Neurons were
positive for the neuron-speciﬁc cytoskeletal marker β-III-tubulin,
nuclear marker NeuN, dendritic marker MAP2, presynaptic marker
Synapsin and postsynaptic marker PSD95 (Figures 1d and e).
Quantiﬁcation of Synapsin and PSD95 puncta conﬁrmed their
frequent colocalization, consistent with synaptic network con-
nectivity, of which ~ 70% were glutamatergic PSD95-labeled
synapses (Figures 1e and f). Moreover, electron microscopy
conﬁrmed a classical synaptic morphology, including presynaptic
vesicle pools and postsynaptic density (Supplementary Figures 2a
and b). Furthermore, the majority of neurons were CTIP2+,
consistent with a glutamatergic lineage identity, and mutually
exclusive of neurons exhibiting GAD67 labeling (Supplementary
Figure 2c). Both glutamatergic and GABAergic synapses were
immunohistochemically conﬁrmed by labeling for VGLUT1 and
GAD67, respectively (Supplementary Figure 2d). The proportion of
immature neurons, mature neurons and astroglia was quantiﬁed
by staining for doublecortin (DCX), NeuN and GFAP, respectively.
Overall, NeuN+ cells constituted 15.9% of all DAPI+ nuclei, and
10.8% expressed the astrocyte marker GFAP. The ratio of
NeuN+ (mature neurons) to GFAP+ (astrocytes) was 59.5 to
40.5% (Figure 1c). The remaining cells were SOX2-expressing
NPCs (59.7%) and DCX-expressing immature neurons (13.6%)
(Supplementary Figure 3).
We next studied the expression of cortical layer-speciﬁc markers
in the differentiated neurons (Figure 2).28,29 Subsets of neurons
were positive for the transcription factor BRN2 that is expressed in
late cortical progenitors and upper layer neurons (II-IV) (Figure 2a),
the cortical-layer marker TBR1 that is expressed in deep layer
neurons (V and VI) and the subplate (Figure 2b), FOXP2 that is
expressed in layers V and VI (Figure 2c), CUX1 and CUX2 expressed
in upper layer neurons (II–IV), SATB2 expressed in layers II-V,
FOXG1 expressed in forebrain neural progenitors and widely in
neurons of the developing telencephalon, and CTIP2 expressed in
glutamatergic projection neurons from layers V and VI
(Figures 2d–f). Juxtasomal neuronal biocytin labeling demon-
strated an elaborate axonal and dendritic morphology. Sholl
analysis was performed to quantify dendritic branching and total
dendritic length (Supplementary Figure 4).
Electrophysiology results
Whole-cell patch-clamp recordings were performed to character-
ize the functional maturity of the iPSC-derived neuronal networks.
Electrophysiological recordings were compared across three
independent lines (Figures 3–5).
Most protocols that have been reported for neuronal differ-
entiation of human pluripotent stem cells employ a semideﬁned
culture medium, whereas electrophysiological recordings are
performed either in the same culture medium or after transferring
from the culture medium directly into a deﬁned ACSF. Impor-
tantly, the use of culture medium for electrophysiological
recordings of neurons has previously been found to impair
spontaneous and evoked ﬁring of action potentials, network-level
spontaneous calcium activity and synaptic activity.16 Notably
however, those experiments involved an immediate switch from
culture medium to ACSF, for which the substantial acute increase
in extracellular osmolarity (from 220 mOsm kg− 1 in culture
medium to 305 mOsm kg− 1 in ACSF) has previously been
reported as highly stressful for neurons.30 Therefore, we imple-
mented a gradual transition from the culture medium to the ACSF
recording medium over 25 min using 5 serial partial exchanges
(see Materials and methods section for details).
Mature APs were deﬁned as being those that reached a
membrane potential above 0 mV, with a fast depolarization
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Figure 1. Generation and characterization of NPCs and neuronal networks from iPSCs. (a) Scheme illustrating the major developmental stages
of the protocol for generating NPCs and neuronal networks. (b) Immunostaining for NPC markers Nestin, SOX2, Vimentin and FOXG1
(scale bars= 30 μm). (c) Proportion of NeuN+ and GFAP+ cells (days 56–70). (d) Immunostaining for glial marker GFAP, and mature neuronal
markers MAP2 and NeuN (top, scale bar= 20 μm; bottom, scale bar= 10 μm). (e) Co-labeling of pre- and postsynaptic marker proteins,
Synapsin and PSD95 (scale bar= 2 μm). (f) Quantiﬁcation of Synapsin+, PSD95+ and double-labeled puncta density (n= 20 neurons). EB,
embryoid body; GFAP, glial ﬁbrillary acidic protein; iPSC, induced pluripotent stem cells; NPC, neural precursor cells.
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Figure 2. Cortical layer markers in neuronal networks. Cultures were stained at day 56 following the initiation of NPC differentiation for
(a) BRN2 marker of late cortical progenitors and upper layer (II-IV) neurons, and mature dendritic marker MAP2, (b) TBR1 that is expressed by
deep layer neurons (V and VI) and in the subplate, (c) FOXP2 expressed in deep layer (V and VI) neurons, (d) CUX1 marker of upper layer (II–IV)
neurons and telencephalic marker FOXG1 and (e) CUX2 marker of upper layer (II–IV) neurons and SATB2 expressed in corticocortical
projection neurons from layer V and upper layers. (f) CTIP2 expression in deep layer glutamatergic projection neurons. NPC, neural precursor
cells.
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(⩽5 ms rise time) and rapid repolarization (⩽10 ms decay time).
Nearly all recorded cells were capable of ﬁring mature APs in
response to depolarizing current injections (111/114 cells, 97.4%).
Among these cells, 79.3% (88/111) exhibited repetitive ﬁring of
mature APs (Figures 3a and b), with a peak frequency of ~ 12 Hz
(Figure 3c). The remaining 20.7% (23/111 neurons) ﬁred an initial
mature AP followed by a sequence of APs that exhibited rapid
accommodation and no longer met the criteria for AP maturity.
Detailed electrophysiological measurements of intrinsic proper-
ties were performed among the group of neurons that were
deﬁned as mature based on their ability to ﬁre mature APs
repetitively in response to current injection. Passive and active
membrane properties were quantiﬁed and compared in order to
evaluate both the electrophysiological maturity of the neurons
and the variability between lines. The mean input resistance
was 1.28 ± 0.05 GΩ (Figure 3d). Resting membrane potential
was − 58.2 ± 1.0 mV (Figure 3e). The average capacitance was
49.1 ± 2.9 pF (Figure 3f). AP threshold was − 50.9 ± 0.5 mV
(Figure 3g). AP amplitude, measured from voltage threshold to
peak, was 66.5 ± 1.3 mV (Figure 3h). AP half-width was
3.18 ± 0.11 ms (Figure 3i). AP rise and decay times were
1.9 ± 1.0 ms (Figure 3j) and 3.36 ± 0.16 ms (Figure 3k), respectively.
Another important aspect of neuronal network maturity is
spontaneous AP ﬁring.31–33 The majority of neurons exhibited
spontaneous APs (59.1%, 52/88 neurons) (Figures 4a and b).
Importantly, sustained high-quality whole-cell recordings could be
maintained for430 min (longest recording time examined) with a
stable membrane potential and AP waveform, conﬁrming that the
presence of spontaneous APs was not the result of declining cell
health (Supplementary Figure 5a). Moreover, spontaneous ﬁring
of APs was also evident in non-permeating cell-attached
recordings, thereby establishing that the presence of spontaneous
APs was not an artifact of the whole-cell conﬁguration
(Supplementary Figure 5b).
In order to conﬁrm that the observed APs were driven by active
sodium channel conductance, we blocked voltage-gated sodium
channels by applying tetrodotoxin to the bath solution in a subset
of recordings. As expected, action potentials were completely
abolished (Figure 4c). Voltage-clamp recordings demonstrated the
presence of fast sodium currents, as evident from the rapid inward
current observed in response to depolarized membrane potentials
(Figure 4d, upper panel, and Figure 4e). Inward voltage-gated
sodium currents were also completely blocked by TTX (Figure 4d,
lower panel).
Another important aspect of neuronal maturity is synaptic
connectivity. Spontaneous synaptic activity was evident in 73.8%
of neurons (Figures 5a–c). The frequency and amplitude of
synaptic events was 1.09 ± 0.17 Hz (Figure 5d) and 16.03 ± 0.82 pA
(Figure 5e), respectively. Line 2 exhibited signiﬁcant pairwise
differences in the amplitude of synaptic events compared
with lines 1 and 3 (F = 7.25, P= 0.001; post hoc Tukey: P= 0.01
for line 1 vs 2, P= 0.004 for line 2 vs 3 and P= 0.52 for line 1 vs 3).
The kinetics of these events resembled those typically
observed from neuronal recordings in acute ex vivo neocortical
tissue slices, with an average rise time of 1.66 ± 0.65 ms
(Figure 5f) and decay time of 5.59 ± 0.48 ms (Figure 5g). Blockade
Figure 3. Active and passive electrophysiological properties. (a) Representative traces from a neuron ﬁring repetitive mature APs during
depolarizing constant-current injections. Current steps are shown in the bottom panel (Vm=− 75 mV). The lowest depolarizing step indicates
the minimal current needed to evoke an action potential, and the highest step corresponds to the current at which the response frequency
became saturated. (b) Percentage of repetitive versus nonrepetitively ﬁring neurons. (c) Frequency–current (F-I) plot among repetitively ﬁring
neurons. (d–k) Active and passive membrane properties. AP parameters were calculated from the ﬁrst evoked spike. (d) Input resistance
(F= 3.65, P= 0.03), (e) resting membrane potential (F= 0.82, P= 0.44), (f) capacitance (F= 0.18, P= 0.84), (g) AP threshold (F= 1.25, P= 0.29), (h)
AP amplitude (F= 1.01, P= 0.37), (i) AP half-width (F= 4.70, P= 0.012), (j) AP rise time (F= 1.23, P= 0.30) and (k) decay time (F= 4.62, P= 0.013).
AP, action potential.
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Figure 4. Spontaneous action potentials. (a) Representative current-clamp recording from a spontaneously active neuron (Vm=− 68 mV). (b)
Percentage of neurons with spontaneous AP ﬁring. (c) Voltage responses of the same neuron in (a) to hyperpolarizing or depolarizing current
injections (bottom panel), before (top panel) and after (middle panel) TTX application (Vm=− 75 mV). (d) Sodium currents were abolished by
TTX (before, top panel; after, bottom panel) (Vm=− 80 mV). (e) Voltage dependence of the peak amplitude of the sodium current.
Figure 5. Neuronal network synaptic activity. (a) Representative voltage-clamp recording from a neuron with spontaneous synaptic input
(Vm=− 80 mV). (b) Zoom-in of the region in (a) marked by the red asterisk, containing two postsynaptic events. (c) Percentage of neurons
exhibiting spontaneous synaptic input. (d–g) Spontaneous postsynaptic currents: (d) frequency (F= 2.55, P= 0.09), (e) amplitude (F= 7.25,
P= 0.001; post hoc Tukey: P= 0.01 for line 1 vs 2, P= 0.004 for line 2 vs 3 and P= 0.52 for line 1 vs 3), (f) rise time (F= 1.24, P= 0.30) and (g)
decay time (P= 0.023, F= 4.01).
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of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
and N-Methyl-D-aspartic acid (NMDA) receptors using
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 50 μM) and (2R)-
amino-5-phosphonovaleric acid (APV, 50 μM) conﬁrmed the
dominant contribution of glutamatergic transmission to the
synaptic network activity (Supplementary Figure 6).
DISCUSSION
We describe the results of a robust simpliﬁed protocol for
neuronal network differentiation from human iPSCs with a
particular focus on electrophysiological maturity. The observed
electrophysiological maturity was achieved using a common iPSC-
derived neural progenitor to obtain both neurons and astrocytes,
thereby obviating the need for exogenous glial cell co-culture. We
observed a consistent 60:40 ratio of neurons to glia, which
included neurons representative of both upper and deep cortical
layers, in addition to a substantial population of NPCs and DCX+
immature neurons. The robustness of the resulting neuronal
networks was further evident by reducing the volume of medium
changes over the course of differentiation, following the rationale
that the emerging neuronal networks become increasingly self-
sufﬁcient.
This protocol requires no specialized media to obtain high-
quality whole-cell patch-clamp recordings from iPSC-derived
neurons with mature electrophysiological properties. We imple-
mented a gradual equilibration procedure to transition cultures
from standard neural differentiation medium to ACSF. The
signiﬁcance of the osmotic environment to the electrophysiolo-
gical properties of iPSC-derived neurons was recently demon-
strated by Bardy et al.,16 who introduced a specialized medium for
neural cell culture and electrophysiological recordings. We now
demonstrate the feasibility of using standard neural differentiation
media while minimizing the physiological response to acute
osmotic changes through a gradual equilibration from culture
medium to ACSF.
Electrophysiological properties are a deﬁning property of
neuronal maturation. Many neuronal electrophysiological para-
meters exhibit signiﬁcant alterations over the course of
neurodevelopment.34–36 Resting membrane potential (Vm) tends
to become progressively more hyperpolarized during neurodeve-
lopment and stabilizes at approximately − 70 mV in human
neocortical ex vivo tissue slices,37 for which our protocol generated
neurons with a comparable average Vm of − 58 mV. Input
resistance also decreases throughout neurodevelopment, as a
result of both a higher ion channel density and a more complex
cell morphology.35,36 Neurons from adult human neocortex have
an input resistance on the order of 50–150 MΩ,37 whereas that of
second-trimester human neocortical neurons is ∼ 2 GΩ.34 Our
protocol generated neurons with an average input resistance of
1.3 GΩ, consistent with a late gestational or early postnatal
neurodevelopmental period. As neurons mature, their AP ﬁring
threshold becomes increasingly hyperpolarized, and the AP
waveform exhibits more rapid kinetics with larger
amplitudes.36,37 Consistent with our measurements of input
resistance, we observed that both AP threshold and AP half-
width were also comparable to neurons recorded from ex vivo
mid-to-late gestational human neocortical tissue.34
The emergence of synaptic transmission is another deﬁning
aspect of neuronal network maturation that is continuously and
dynamically regulated by short- and long-term forms of plasticity,
and considered among the latest developing aspects of neuronal
physiology.38 Consistent with the estimated neurodevelopmental
stage of the passive membrane properties and active AP
characteristics in neurons derived using the current protocol, the
synaptic parameters we measured are also comparable to those
observed in mid-to-late gestational human neocortex.34 However,
in contrast to the low variability that we observed across different
lines regarding passive membrane and AP characteristics, synaptic
properties exhibited a generally higher variance. Synapse forma-
tion and synaptic function develop over an extended period in
neurodevelopment and are governed by a sizeable proportion of
the genome, with ~ 9% of all protein-coding genes expressed at
mammalian excitatory synapses.39,40 Accordingly, for iPSC-based
functional genomic studies of neurophysiology, isogenic controls
may be particularly important for investigating synaptic function.
In contrast, AP parameters and passive membrane properties
appear to be more robust across differing genetic backgrounds.
In summary, we have developed a simpliﬁed differentiation
protocol for generating electrophysiologically mature iPSC-
derived neuronal networks without the need for astrocyte
co-culture or specialized media. Moreover, our ﬁndings provide
a quantitative basis for considering the variability of distinct
electrophysiological parameters for iPSC-based disease modeling.
We envision this protocol to be of considerable utility for
implementing cellular modeling approaches to the study of
human neuropsychiatric disease pathophysiology.
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